The biotech giant posted positive trial results of a cancer vaccine, boosting shares at a record-setting pace before investors pulled back.
Modernas stock retreated on Thursday following a record-setting jump a day earlier, cutting more than $18 billion from the companys market valuation, as investors appeared to pull back after the biot… [+2849 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account